Essex Bio-Technology Limited (1061.HK)

HKD 4.45

(-3.05%)

Long Term Debt Summary of Essex Bio-Technology Limited

Essex Bio-Technology Limited's latest annual long term debt in 2023 was 36.05 Million HKD , down -90.56% from previous year.
Essex Bio-Technology Limited's latest quarterly long term debt in 2024 Q2 was 68.82 Million HKD , down 0.0% from previous quarter.
Essex Bio-Technology Limited reported annual long term debt of 382.12 Million HKD in 2022, down -6.63% from previous year.
Essex Bio-Technology Limited reported annual long term debt of 409.27 Million HKD in 2021, up 13.76% from previous year.
Essex Bio-Technology Limited reported quarterly long term debt of 36.05 Million HKD for 2023 FY, down -90.56% from previous quarter.
Essex Bio-Technology Limited reported quarterly long term debt of 354.96 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Essex Bio-Technology Limited (2023 - 2000)

Historical Annual Long Term Debt of Essex Bio-Technology Limited (2023 - 2000)

Year	Long Term Debt	Long Term Debt Growth
2023	36.05 Million HKD	-90.56%
2022	382.12 Million HKD	-6.63%
2021	409.27 Million HKD	13.76%
2020	359.76 Million HKD	2.83%
2019	349.87 Million HKD	84.76%
2018	189.36 Million HKD	46.82%
2017	128.97 Million HKD	6.21%
2016	121.43 Million HKD	0.0%
2015	- HKD	0.0%
2014	- HKD	0.0%
2013	- HKD	0.0%
2012	- HKD	0.0%
2011	- HKD	0.0%
2010	- HKD	0.0%
2009	- HKD	0.0%
2008	- HKD	0.0%
2007	- HKD	0.0%
2006	- HKD	0.0%
2005	- HKD	0.0%
2004	- HKD	-100.0%
2003	72.53 Thousand HKD	-74.91%
2002	289.08 Thousand HKD	0.0%
2001	- HKD	-100.0%
2000	11.6 Million HKD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	68.82 Million HKD	0.0%
2023 FY	36.05 Million HKD	-90.56%
2023 Q2	354.96 Million HKD	0.0%
2023 Q4	36.05 Million HKD	0.0%
2022 Q2	398.62 Million HKD	0.0%
2022 FY	382.12 Million HKD	-6.63%
2022 Q4	382.12 Million HKD	0.0%
2021 Q2	373.78 Million HKD	0.0%
2021 Q4	409.27 Million HKD	0.0%
2021 FY	409.27 Million HKD	13.76%
2020 Q2	148.99 Million HKD	0.0%
2020 FY	359.76 Million HKD	2.83%
2020 Q4	359.76 Million HKD	0.0%
2019 Q4	349.87 Million HKD	0.0%
2019 Q2	225.54 Million HKD	0.0%
2019 FY	349.87 Million HKD	84.76%
2018 Q2	186.6 Million HKD	0.0%
2018 Q4	189.36 Million HKD	0.0%
2018 FY	189.36 Million HKD	46.82%
2017 FY	128.97 Million HKD	6.21%
2017 Q2	126.25 Million HKD	0.0%
2017 Q4	128.97 Million HKD	0.0%
2016 Q4	121.43 Million HKD	0.0%
2016 Q2	- HKD	0.0%
2016 FY	121.43 Million HKD	0.0%
2015 Q4	- HKD	0.0%
2015 Q2	- HKD	0.0%
2015 FY	- HKD	0.0%
2014 Q2	- HKD	0.0%
2014 Q4	- HKD	0.0%
2014 FY	- HKD	0.0%
2013 Q4	- HKD	0.0%
2013 FY	- HKD	0.0%
2013 Q2	- HKD	0.0%
2012 Q4	- HKD	0.0%
2012 FY	- HKD	0.0%
2012 Q2	- HKD	0.0%
2011 FY	- HKD	0.0%
2011 Q4	- HKD	0.0%
2011 Q2	- HKD	0.0%
2010 Q2	- HKD	0.0%
2010 FY	- HKD	0.0%
2009 FY	- HKD	0.0%
2008 FY	- HKD	0.0%
2007 FY	- HKD	0.0%
2006 FY	- HKD	0.0%
2005 FY	- HKD	0.0%
2004 FY	- HKD	-100.0%
2003 FY	72.53 Thousand HKD	-74.91%
2002 FY	289.08 Thousand HKD	0.0%
2001 FY	- HKD	-100.0%
2000 FY	11.6 Million HKD	0.0%

Peer Long Term Debt Comparison of Essex Bio-Technology Limited

Name	Long Term Debt	Long Term Debt Difference
Pak Fah Yeow International Limited	2.07 Million HKD	-1639.351%
Grand Pharmaceutical Group Limited	990.02 Million HKD	96.358%
Extrawell Pharmaceutical Holdings Limited	117.12 Million HKD	69.215%
Wai Yuen Tong Medicine Holdings Limited	276.2 Million HKD	86.945%
Qianhai Health Holdings Limited	- HKD	-Infinity%
Lee's Pharmaceutical Holdings Limited	70.63 Million HKD	48.954%
Tongfang Kontafarma Holdings Limited	12.8 Million HKD	-181.671%
PuraPharm Corporation Limited	81.09 Million HKD	55.537%
SSY Group Limited	1.94 Billion HKD	98.149%
JBM (Healthcare) Limited	43.8 Million HKD	17.679%
Jacobson Pharma Corporation Limited	592.2 Million HKD	93.911%
China Resources Pharmaceutical Group Limited	16.61 Billion HKD	99.783%